Vaccines of Jammu and Kashmir have been stopped.
Through P Bannan / MediaNews Group / Daily Local News
- The United States suspended the rollout of the J&J vaccine after reports that six women developed blood clots.
- This week, South Africa also suspended the rollout of the Jammu and Kashmir vaccine.
- Experts say that people are more likely to see side effects after being vaccinated.
There are no cases of blood coagulation disorders after vaccination in Africa, but the World Health Organization’s (WHO) Global Advisory Committee on Vaccine Safety closely monitored the Johnson & Johnson vaccine after blood clots from six women in the United States Has been.
Dr. for vaccination and vaccine development by WHO’s Africa Program Area Manager. Richard Mihigo revealed this during a webinar on Thursday.
Due to blood clots, the US Food and Drug Administration suspended the rollout of the Jammu and Kashmir vaccine.
Shortly after the announcement, South Africa also postponed its plans for the rollout of the vaccine.
Mihigo stated that “there were no cases of blood coagulation disorders reported after vaccination in Africa”. Mihigo said the monitoring system shows that most reports are of either mild to moderate side effects.
He said that the top-reported side-effects in Africa are headache, fever, nausea, pain, and numbness.
Mihigo said that there are more than 4.3 million confirmed cases of Kovid-19 in Africa, while more than 45 countries are vaccinated.
READ | Kovid-19 loan guarantee scheme extended for three months
More than 13.8 million doses of the vaccine have been administered, and Mihigo said there are encouraging signs that Africa’s monitoring and reporting systems are working well.
“In recent times, we have seen the United States take precautionary measures by preventing the rollout of the Johnson & Johnson vaccine. [after] Report of blood clots after vaccination. As we have seen, South Africa also announced that it would temporarily halt the vaccine rollout.
“The World Health Organization’s Global Advisory Committee on Vaccine Safety is closely following the developments and will share any findings as soon as possible.”
Mihigo said that Kovid-19 has lost nearly three million lives worldwide – and WHO considers the benefits of the vaccine far from risk.
They stated that Kovid-19 vaccines are safe and can significantly reduce the risk of serious illness and death.
During the webinar, doctors said that people are likely to see more side effects of Kovid-19 vaccines after getting vaccinated. These side effects may not have been observed during clinical studies.
Tumalo Semet, CEO of SA Health Products Regulatory Authority, said that when it comes to clinical trials, there are limitations because the vaccine is tested in small numbers.
Semet said: “As you start to rollout, there are side-effects that you have never seen in a clinical trial because with a rollout, you would be in a much larger population group than you would be in a clinical trial. Are taking advantage.
“We will continue to monitor them as they come – but, at this point, we have not seen this effect to the same extent, if any, in the South African context.”